JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Omnicell Inc

Cerrado

SectorSanidad

36.36 -0.95

Resumen

Variación precio

24h

Actual

Mínimo

35.74

Máximo

36.97

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

945

60.328

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+59.62% upside

Dividendos

By Dow Jones

Próximas Ganancias

28 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-518M

1.7B

Apertura anterior

37.31

Cierre anterior

36.36

Noticias sobre sentimiento de mercado

By Acuity

7%

93%

310 / 348 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 abr 2026, 23:47 UTC

Charlas de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 abr 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 abr 2026, 22:33 UTC

Ganancias

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 abr 2026, 22:17 UTC

Ganancias

PLS Executed Offtake Agreement With Ronbay

23 abr 2026, 22:17 UTC

Ganancias

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 abr 2026, 22:16 UTC

Ganancias

PLS Commences Commissioning of Midstream Demonstration Plant

23 abr 2026, 22:15 UTC

Ganancias

PLS Group Reaffirms FY26 Guidance for All Metrics

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 abr 2026, 22:13 UTC

Ganancias

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:11 UTC

Ganancias

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 abr 2026, 22:10 UTC

Ganancias

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 abr 2026, 22:09 UTC

Ganancias

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 abr 2026, 22:08 UTC

Ganancias

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 abr 2026, 22:04 UTC

Ganancias

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 abr 2026, 21:56 UTC

Charlas de Mercado
Ganancias

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 abr 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 abr 2026, 21:27 UTC

Ganancias

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 abr 2026, 21:25 UTC

Ganancias

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 abr 2026, 21:24 UTC

Ganancias

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 abr 2026, 21:24 UTC

Ganancias

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 abr 2026, 21:21 UTC

Ganancias

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 abr 2026, 21:21 UTC

Ganancias

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

59.62% repunte

Estimación a 12 Meses

Media 58.5 USD  59.62%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

310 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat